Johnson & Johnson (NYSE:JNJ) will host a review of its Pharmaceutical businesses for the investment community beginning at 8:30 AM Eastern Time on Wednesday, May 17, 2017 at the Hyatt Regency Hotel in New Brunswick, New Jersey.
Alex Gorsky, Chairman and Chief Executive Officer, will provide opening remarks. Highlights of the day will include speakers from Johnson & Johnson’s Executive and Management Committee as well as leaders from the therapeutic areas within the Pharmaceutical Research and Development organization.
Investors and other interested parties may access this meeting by visiting the website at www.investor.jnj.com for a simultaneous webcast of the presentations.
A replay and podcast will be available shortly after the live webcast.